These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Fluoxetine and schizophrenia in a patient with obsessional thinking. Baker RW J Neuropsychiatry Clin Neurosci; 1992; 4(2):232-3. PubMed ID: 1627986 [No Abstract] [Full Text] [Related]
43. Fluoxetine in chronic schizophrenia. Lindenmayer JP; Vakharia M; Kanofsky D J Clin Psychopharmacol; 1990 Feb; 10(1):76. PubMed ID: 2307741 [No Abstract] [Full Text] [Related]
44. Fluoxetine and the serotonin syndrome. Ruiz F Ann Emerg Med; 1994 Nov; 24(5):983-5. PubMed ID: 7978579 [TBL] [Abstract][Full Text] [Related]
45. Clinical evaluation of bromperidol versus haloperidol in psychotic patients. Denijs EL Int Pharmacopsychiatry; 1980; 15(5):309-17. PubMed ID: 7021451 [TBL] [Abstract][Full Text] [Related]
48. Patterns of response to amitriptyline and haloperidol among borderline patients. Soloff PH; George A; Nathan RS; Schulz P; Cornelius J Psychopharmacol Bull; 1988; 24(2):264-8. PubMed ID: 3212160 [No Abstract] [Full Text] [Related]
49. Tardive dyskinesia in a patient taking haloperidol and fluoxetine. Stein MH Am J Psychiatry; 1991 May; 148(5):683. PubMed ID: 2018175 [No Abstract] [Full Text] [Related]
50. The serotonin syndrome associated with paroxetine, an over-the-counter cold remedy, and vascular disease. Skop BP; Finkelstein JA; Mareth TR; Magoon MR; Brown TM Am J Emerg Med; 1994 Nov; 12(6):642-4. PubMed ID: 7945606 [TBL] [Abstract][Full Text] [Related]
51. [Effects of thiothixene on schizophrenic symptoms in a long-term therapeutic scheme. Comparative study with butyrophenone derivative]. Vianna Filho U; Muniz AF; Terra SO; Bueno JR J Bras Psiquiatr; 1971; 20(3):193-204. PubMed ID: 5164436 [No Abstract] [Full Text] [Related]
56. [Delirious syndrome following administration of haloperidol]. Amielańczyk W Psychiatr Pol; 1973; 7(2):218-21. PubMed ID: 4710995 [No Abstract] [Full Text] [Related]
57. Serum lipids and lipoproteins in schizophrenic patients receiving major tranquilizers. Shafique M; Khan IA; Akhtar MH; Hussain I J Pak Med Assoc; 1988 Oct; 38(10):259-61. PubMed ID: 3144603 [No Abstract] [Full Text] [Related]
58. Somatostatin-like immunoreactivity in CSF in schizophrenic patients during haloperidol treatment. Jolkkonen J; Pitkänen A; Riekkinen PJ; Korpi ER; Kaufmann CA; Weinberger DR Biol Psychiatry; 1992 May; 31(9):962-4. PubMed ID: 1637934 [No Abstract] [Full Text] [Related]